Mirova Biogen Inc. Transaction History

Mirova

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $4,229 - $5,090	-19 Reduced 5.49%	327 $84,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $124,623 - $140,657	-492 Reduced 58.71%	346 $88,000
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $234,788 - $271,305	-853 Reduced 50.44%	838 $238,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $505,679 - $576,202	-1,971 Reduced 53.82%	1,691 $470,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $175,445 - $213,170	695 Added 23.42%	3,662 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $27,451 - $37,852	141 Added 4.99%	2,967 $792,000
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $529,988 - $630,254	2,826 New	2,826 $576,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $122,036 - $156,834	-545 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $13,583 - $17,714	48 Added 9.66%	545 $154,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $19,678 - $23,055	81 Added 19.47%	497 $139,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $63,081 - $94,953	267 Added 179.19%	416 $101,000
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $29,389 - $33,933	111 Added 292.11%	149 $42,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $8,362 - $11,554	38 New	38 $11,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

Stay updated on Mirova with notifications on news.